Joel Posener
Joel Posener
Early Clinical Development at AstraZeneca Neuroscience Innovative Medicines (iMed), USA
Biography
Joel Posener, MD, is the Head of Clinical Development in the AstraZeneca Neuroscience Innovative Medicines unit, which is responsible for the company's discovery and early development efforts in psychiatry, neurology and pain. Dr. Posener is a board certified psychiatrist with more than 10 years of experience in each of academic medicine and the pharmaceutical industry. He has broad experience in drug development, encompassing Phases 1-3, clinical pharmacology, translational medicine, and multiple indications in psychiatry and neurology, including schizophrenia (psychosis and cognitive impairment), depression, bipolar disorder, Alzheimer Disease, Parkinson's Disease (symptomatic and disease modification), other movement disorders, pain (various types), and orphan diseases. In addition to his primary responsibility at AstraZeneca, Dr. Posener serves on the faculty at Temple University School of Medicine, where he is Clinical Professor of Psychiatry.
Research Interest
Psychiatry
NeuroScience